PLN Chromosome 6
Phospholamban
Upload your DNA to see your personal genotypes for variants in PLN.
What This Gene Does
The protein encoded by this gene is found as a pentamer and is a major substrate for the cAMP-dependent protein kinase in cardiac muscle. The encoded protein is an inhibitor of cardiac muscle sarcoplasmic reticulum Ca(2+)-ATPase in the unphosphorylated state, but inhibition is relieved upon phosphorylation of the protein. The subsequent activation of the Ca(2+) pump leads to enhanced muscle relaxation rates, thereby contributing to the inotropic response elicited in heart by beta-agonists. The encoded protein is a key regulator of cardiac diastolic function. Mutations in this gene are a cause of inherited human dilated cardiomyopathy with refractory congestive heart failure, and also familial hypertrophic cardiomyopathy. [provided by RefSeq, Apr 2016]
Gene Info
Gene Group
Regulins
Locus Type
gene with protein product
Location
6q22.31
Ensembl
ENSG00000198523
Associated Conditions (13)
Dilated cardiomyopathy 1P
Cardiomyopathy
Cardiovascular phenotype
Primary dilated cardiomyopathy
Hypertrophic cardiomyopathy 18
Hypertrophic cardiomyopathy
Arrhythmogenic right ventricular dysplasia 9
SUDDEN INFANT DEATH SYNDROME
PLN-related cardiomyopathy
Sudden cardiac death
Cardiac arrest
Intrinsic cardiomyopathy
PLN-related disorder
Key Variants
RS145623013
Conflicting classifications of pathogenicity
Dilated cardiomyopathy 1P, Cardiomyopathy, Cardiovascular phenotype
Health Risk
RS1779072006
Conflicting classifications of pathogenicity
Dilated cardiomyopathy 1P, Cardiovascular phenotype, Dilated cardiomyopathy 1P
Health Risk
RS189611501
Conflicting classifications of pathogenicity
Dilated cardiomyopathy 1P, Dilated cardiomyopathy 1P
Health Risk
RS397516785
Conflicting classifications of pathogenicity
Dilated cardiomyopathy 1P, Dilated cardiomyopathy 1P
Health Risk
RS727503374
Conflicting classifications of pathogenicity
Dilated cardiomyopathy 1P, Cardiovascular phenotype, Dilated cardiomyopathy 1P
Health Risk
RS754782171
Conflicting classifications of pathogenicity
Dilated cardiomyopathy 1P, Cardiovascular phenotype, Dilated cardiomyopathy 1P
Health Risk
RS761056344
Conflicting classifications of pathogenicity
Dilated cardiomyopathy 1P, Primary dilated cardiomyopathy, Cardiovascular phenotype
Health Risk
RS868301643
Conflicting classifications of pathogenicity
Dilated cardiomyopathy 1P, Cardiovascular phenotype, Dilated cardiomyopathy 1P
Health Risk
RS970310064
Conflicting classifications of pathogenicity
Health Risk
RS794729138
Likely pathogenic
Cardiomyopathy, Hypertrophic cardiomyopathy, Dilated cardiomyopathy 1P
Health Risk
RS111033559
Pathogenic
Dilated cardiomyopathy 1P, Primary dilated cardiomyopathy, Cardiomyopathy
Health Risk
RS1779066083
Pathogenic
Dilated cardiomyopathy 1P, Dilated cardiomyopathy 1P
Health Risk
All Variants (17)
| RSID | Category | Clinical Significance | Conditions |
|---|---|---|---|
| RS145623013 | Health Risk | Conflicting classifications of pathogenicity | Dilated cardiomyopathy 1P, Cardiomyopathy, Cardiovascular phenotype |
| RS1779072006 | Health Risk | Conflicting classifications of pathogenicity | Dilated cardiomyopathy 1P, Cardiovascular phenotype, Dilated cardiomyopathy 1P |
| RS189611501 | Health Risk | Conflicting classifications of pathogenicity | Dilated cardiomyopathy 1P, Dilated cardiomyopathy 1P |
| RS397516785 | Health Risk | Conflicting classifications of pathogenicity | Dilated cardiomyopathy 1P, Dilated cardiomyopathy 1P |
| RS727503374 | Health Risk | Conflicting classifications of pathogenicity | Dilated cardiomyopathy 1P, Cardiovascular phenotype, Dilated cardiomyopathy 1P |
| RS754782171 | Health Risk | Conflicting classifications of pathogenicity | Dilated cardiomyopathy 1P, Cardiovascular phenotype, Dilated cardiomyopathy 1P |
| RS761056344 | Health Risk | Conflicting classifications of pathogenicity | Dilated cardiomyopathy 1P, Primary dilated cardiomyopathy, Cardiovascular phenotype |
| RS868301643 | Health Risk | Conflicting classifications of pathogenicity | Dilated cardiomyopathy 1P, Cardiovascular phenotype, Dilated cardiomyopathy 1P |
| RS970310064 | Health Risk | Conflicting classifications of pathogenicity | — |
| RS794729138 | Health Risk | Likely pathogenic | Cardiomyopathy, Hypertrophic cardiomyopathy, Dilated cardiomyopathy 1P |
| RS111033559 | Health Risk | Pathogenic | Dilated cardiomyopathy 1P, Primary dilated cardiomyopathy, Cardiomyopathy |
| RS1779066083 | Health Risk | Pathogenic | Dilated cardiomyopathy 1P, Dilated cardiomyopathy 1P |
| RS2114969441 | Health Risk | Pathogenic | Dilated cardiomyopathy 1P, Dilated cardiomyopathy 1P |
| RS2114970035 | Health Risk | Pathogenic | Dilated cardiomyopathy 1P, Dilated cardiomyopathy 1P |
| RS397516784 | Health Risk | Pathogenic | Primary dilated cardiomyopathy, Cardiomyopathy, Dilated cardiomyopathy 1P |
| RS747947483 | Health Risk | Pathogenic | Dilated cardiomyopathy 1P, Dilated cardiomyopathy 1P |
| RS111033560 | Health Risk | Pathogenic/Likely pathogenic | Dilated cardiomyopathy 1P, Hypertrophic cardiomyopathy 18, Sudden cardiac death |